Make sharper portfolio and capital decisions.

We shape corporate strategy, strengthen portfolio choices, and connect those decisions to resourcing, partnerships, M&A, and procurement.

Schedule a Conversation

Portfolio & Pipeline Strategy

Connect pipeline ambition to clear resourcing decisions.

We assess portfolio health, identify where investment is over or underweighted, and connect pipeline scenarios to resource requirements. Our approach combines vision alignment, portfolio tools, and AI/ML-enabled intelligence to support clearer prioritization and planning.

Related Case Studies

360 Portfolio Oversight Toolkit and Data Hub

Program planning & analytics using standardized templates and scalable data model to enable real-time, 360 portfolio oversight.

Embedding Portfolio-Level Forecasting Capabilities

Portfolio-level forecasting, valuation, and corporate strategy.

Enterprise Resource Forecasting and Planning

Resource forecasting and planning for a top 10 biopharma to address resource bottlenecks and inform prioritization.

Mergers & Acquisitions

Strengthen the decisions behind growth through M&A.

We support life sciences organizations across diligence, value assessment, and integration, combining scientific, market, and operational perspectives to evaluate opportunities and translate transactions into executable portfolio and operating decisions.

Related Case Studies

Change Management & Communications for R&D Integration

Successful acquisition through leading change management, fostering staff engagement, and addressing training needs.

Integration of Large Pharma Clinical Development & Drug Supply

Guidance of a large pharma merger through establishing integration governance, redesigning clinical supply operations, and validating IT systems.

Post-Merger Integration of Large Pharma & Pre- Commercial Biotech

Seamless integration through a core PMO to ensure on-time integration and maximum value capture.

Strategic Partnerships & Alliances

Build partnerships around the capabilities you need.

We evaluate where external partners improve speed, cost, or capability, from CRO and FSP selection to CDMO, digital, and AI/ML partnerships, and structure relationships around the operating need.

Related Case Studies

CDMO Manufacturing Network Partnerships

Streamlining of a CDMO manufacturing network partnerships for a Top-10 biopharma.

Optimizing Biometry Delivery and Cost via an FSP model

Identification and implementation of an optimal biometry FSP support model for a rapidly growing biopharma company.

Sourcing Strategy Strategic Re-Alignment and Execution Support

Identifying, negotiating and driving operations for $750M+ CRO partnerships for a rapidly growing biopharma.

Global Procurement Excellence

Procurement that funds the pipeline.

We redesign procurement operating models, harmonize sourcing processes, and strengthen supplier management. The work connects cost, governance, and operating effectiveness so procurement can support broader strategic priorities.

Related Case Studies

CRO Sourcing Strategy Realignment and Execution for Global Biopharma

Strategic redesign of CRO partnerships to reduce costs, improve delivery, and enhance quality oversight.

Procurement Organization Redesign for Operational Excellence

Transformation of a fragmented procurement structure into a centralized, data-driven organization to improve efficiency, governance, and cost performance.

Turn the next strategic decision into a clear path forward.

Whether the challenge is portfolio prioritization, a transaction, a partnership, or sourcing strategy, we connect the decision with you to the execution that realizes it.

Schedule a Conversation

Explore Our Perspectives

See how we’re thinking about portfolio strategy, transactions, partnerships, and the decisions shaping life sciences growth.

Explore Our Perspectives

Make sharper portfolio and capital decisions.

Explore Our Corporate, Portfolio, & G&A Capabilities

Portfolio & Pipeline Strategy

Mergers & Acquisitions

Strategic Partnerships & Alliances

Global Procurement Excellence

From Our Perspectives

Decision Latency Is a Growth Strategy Problem: Redesigning Portfolio Governance for Speed and Discipline

AI Is Not Ready to Be the Decision-Maker, And Pretending Otherwise Is the Real Risk

Stop Asking Build vs. Buy: Most Biotechs Don't Have an AI Strategy at All

Turn the next strategic decision into a clear path forward.

Explore Our Perspectives

Explore Our Perspectives